Not applicableUnknownNCT04021212What this trial is testingPituitary Adenoma and Serum LipidWho this might be right forPituitary Adenoma 1, Acth-Secreting Shandong Provincial Hospital 1,000
Not applicableEnded earlyNCT04121988What this trial is testingDiagnostic Yield of Deep Learning Based Denoising MRI in Cushing's DiseaseWho this might be right forPituitary ACTH Secreting Adenoma Asan Medical Center 15
Not applicableLooking for participantsNCT07463625What this trial is testingEvaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors.Who this might be right forCushing DiseaseACTH-producing Pituitary Tumour Hospices Civils de Lyon 20
Testing effectiveness (Phase 2)Study completedNCT00171951What this trial is testingExtension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's DiseaseWho this might be right forCushing Disease Novartis Pharmaceuticals 19
Not applicableUnknownNCT03343470What this trial is testingThe Circadian Rhythm in CusHing SyndrOme in Active Phase and dUring RemiSsion (TheHOURS)Who this might be right forCushing Syndrome University of Roma La Sapienza 15
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Large-scale testing (Phase 3)Study completedNCT00569582What this trial is testingThe Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's SyndromeWho this might be right forCushing's Syndrome Corcept Therapeutics 50
Not applicableStudy completedNCT02310269What this trial is testingLong Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's DiseaseWho this might be right forCushings Disease RECORDATI GROUP 152
Testing effectiveness (Phase 2)Ended earlyNCT00958841What this trial is testingStudy of Pasireotide in Patients With Rare Tumors of Neuroendocrine OriginWho this might be right forPancreatic NeoplasmPituitary NeoplasmNelson Syndrome+1 more Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Ended earlyNCT01915303What this trial is testingStudy of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's DiseaseWho this might be right forCushings Disease Novartis Pharmaceuticals 68
Not applicableStudy completedNCT02568982What this trial is testingCushing's Disease ComplicationsWho this might be right forCushing's Disease Assistance Publique - Hôpitaux de Paris 80
Large-scale testing (Phase 3)Study completedNCT03621280What this trial is testingOpen-label Treatment in Cushing's SyndromeWho this might be right forCushing SyndromeCushing Disease Cortendo AB 51
Post-approval studies (Phase 4)Study completedNCT03080181What this trial is testingAdipokine Profile in Patients With Cushing's Disease on Pasireotide TreatmentWho this might be right forCushing Disease University of Palermo 24
Large-scale testing (Phase 3)Study completedNCT01319994What this trial is testingPrevention of Metabolic Complications of Glucocorticoid ExcessWho this might be right forIatrogenic Cushing Disease Barts & The London NHS Trust 57
Testing effectiveness (Phase 2)WithdrawnNCT00003514What this trial is testingAntineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation TherapyWho this might be right forMerkel Cell CarcinomaIslet Cell CarcinomaNeuroendocrine Carcinoma+1 more Burzynski Research Institute
Not applicableStudy completedNCT03346954What this trial is testingImpact of [11C]-Methionine PET/MRI in the Detection of Pituitary Adenomas Secreting ACTH and Causing Cushing's DiseaseWho this might be right forCushing's Disease Hospices Civils de Lyon 33
Not applicableUnknownNCT01775332What this trial is testingInterdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education ToolsWho this might be right forPituitary NeoplasmsProlactinomaACTH-Secreting Pituitary Adenoma+2 more Unity Health Toronto 60
Testing effectiveness (Phase 2)Study completedNCT00088608What this trial is testingAssess SOM230 in Patients With Pituitary Cushing's DiseaseWho this might be right forCushing's Syndrome Novartis Pharmaceuticals 26
Large-scale testing (Phase 3)Study completedNCT01582061What this trial is testingAn Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.Who this might be right forCushing's Disease Novartis Pharmaceuticals 104
Large-scale testing (Phase 3)Study completedNCT01374906What this trial is testingEfficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's DiseaseWho this might be right forCushing's Disease Novartis Pharmaceuticals 150